US 8227455
Methods of treating cell proliferative disorders
granted A61KA61K31/505A61K31/5383
Quick answer
US patent 8227455 (Methods of treating cell proliferative disorders) held by Rigel Pharmaceuticals, Inc. expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61K, A61K31/505, A61K31/5383, A61K31/542, A61P